AMPH
Amphastar Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$23.62
−0.84%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $0.86
- Revenue estimate
- $197.9M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.91
- EPS estimate
- $0.62
- Revenue actual
- $183.9M
- Revenue estimate
- $179.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +11.8%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $21
- PT range
- $20 – $23
- Analysts
- 4
0 Buy3 Hold1 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.62 | $0.91 | Beat 46.77% | $183.9M |
| May 7, 2026 | $0.70 | $0.42 | Miss -40.00% | $171.2M |
| Nov 6, 2025 | $0.77 | $0.93 | Beat 20.78% | $191.8M |
| Aug 7, 2025 | $0.71 | $0.85 | Beat 19.72% | $174.4M |
| Feb 27, 2025 | $1.01 | $0.92 | Miss -8.91% | $186.5M |
| Feb 28, 2024 | $0.93 | $0.88 | Miss -5.38% | $178.1M |
| Feb 28, 2023 | $0.41 | $0.73 | Beat 78.05% | $135.0M |
| Mar 10, 2022 | $0.36 | $0.42 | Beat 16.67% | $120.9M |
| May 6, 2021 | $0.19 | $0.27 | Beat 40.63% | $103.0M |
| Mar 15, 2021 | $0.14 | $0.16 | Beat 15.11% | $95.9M |
| Nov 6, 2020 | $0.13 | $0.15 | Beat 15.38% | $83.4M |
| Aug 6, 2020 | $0.11 | $0.16 | Beat 45.45% | $85.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026